Skip to main content

Table 5 Tumor control and survival of the patients in the TME and CCRT + TME groups

From: Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

Group

3-year rate (%)

Local recurrence (cases [%])

Distant metastasis (cases [%])

DFS

OS

TME

85.7

90.7

4 (4.3)

12 (12.8)

CCRT + TME

87.9

92.3

4 (4.4)

9 (10.0)

P

0.766

0.855

0.776

0.834